4//SEC Filing
Mayer Eldon C. III 4
Accession 0001209191-21-020588
CIK 0001305253other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:31 PM ET
Size
7.3 KB
Accession
0001209191-21-020588
Insider Transaction Report
Form 4
Mayer Eldon C. III
Director
Transactions
- Award
Common Stock
2021-03-12+11,875→ 47,685 total - Award
Stock Option (Right to Buy)
2021-03-12+71,250→ 71,250 totalExercise: $9.99Exp: 2031-03-11→ Common Stock (71,250 underlying)
Footnotes (2)
- [F1]Represents shares underlying Restricted Stock Units award that will vest in three equal annual installments measured from March 12, 2021.
- [F2]The option vests in equal monthly installments over 48 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001686952
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 7:31 PM ET
- Size
- 7.3 KB